Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. Januar 2025 04:06 ET | Quelle: Pharma Equity Group A/S

Pharma Equity Group Finanskalender for 2025

14. januar 2025 Pressemeddelelse Pharma Equity GroupFinanskalender for 2025 4. martsFrist for aktionærforslag - Ordinær generalforsamling 20. marts Årsrapport 2024 16. aprilOrdinær...
14. Januar 2025 04:06 ET | Quelle: Pharma Equity Group A/S

Pharma Equity Group 2025 Financial Calendar

14 January 2025 News Release Pharma Equity Group2025 Financial Calendar March 4Deadline for shareholder proposals - Annual General meeting March 20 Annual Report 2024 April 16Annual General...
13. Dezember 2024 06:21 ET | Quelle: Pharma Equity Group A/S

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

Bestyrelsens beslutning om ny eksekveringsstrategi og prioritering af kliniske områder i Reponex Pharmaceuticals A/S. 13. december 2024Selskabsmeddelelse nr. 32 Pharma Equity Group...
13. Dezember 2024 06:21 ET | Quelle: Pharma Equity Group A/S

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. December 13, 2024Announcement No. 32 Pharma Equity Group...
29. November 2024 01:45 ET | Quelle: Pharma Equity Group A/S

Martin Engell-Rossen skal fremover være kabinetschef for Danmarks nye EU-kommissær Dan Jørgensen i Bruxelles og udtræder derfor af bestyrelsen i Pharma Equity Group A/S

29 november 2024Meddelelse nr. 31 Martin Engell-Rossen skal fremover være kabinetschef for Danmarks nye EU-kommissær Dan Jørgensen i Bruxelles og udtræder derfor af bestyrelsen i Pharma...
29. November 2024 01:45 ET | Quelle: Pharma Equity Group A/S

Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

29 November 2024Announcement No. 31 Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of...
15. November 2024 02:33 ET | Quelle: Pharma Equity Group A/S

Konsolideret delårsrapport 1. januar – 30. september 2024

Konsolideret delårsrapport 1. januar – 30. september 2024 Selskabsmeddelelse nr. 30 – 15. november 2024 Hovedpunkter fra delårsrapporten for perioden 1. januar - 30. september 2024 ...
15. November 2024 02:33 ET | Quelle: Pharma Equity Group A/S

Consolidated Interim report 1 January – 30 September 2024

Consolidated Interim report 1 January – 30 September 2024 Company announcement no. 30 – November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15...
23. Oktober 2024 04:28 ET | Quelle: Pharma Equity Group A/S

Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har opnået patentbeskyttelse i Japan på behandling af colorectal cancer med RNX-051.

Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har opnået patentbeskyttelse i Japan på behandling af colorectal cancer med RNX-051. 23. oktober 2024 Selskabsmeddelelse nr. 29 ...
23. Oktober 2024 04:28 ET | Quelle: Pharma Equity Group A/S

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement...

Vorherige Seite

Nächste Seite